New Executive Order Seeks to Lower Drug Prices and Improve PBM Transparency - On April 15, 2025, President Donald Trump issued an executive order (EO) that directs his administration to take a wide range of actions to...

Read More

GLP-1s and Biosimilars Reshape Prescription Drug Market - Inflation, additional treatment options approved by the U.S. Food and Drug Administration (FDA) and increased utilization of high-cost medications led to rising...

Read More

CMS has provided two model notices for employers to use: Medicare Part D Notices Are Due Before Oct. 15, 2024 - Each year, Medicare Part D requires group health plan sponsors to disclose to individuals who are eligible...

Read More